RecruitingNot applicableNCT05679349
Official study title

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Study summary

This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedSurvey Administration and Educational Activity

Plus 6 other study approaches.

Who it may be forLung Carcinoma · Tobacco-Related Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 29, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Ronald Myers

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Ronald Myers
Interventions being studied
Other: Survey Administration; Other: Educational Activity; Other: Survey Administration; Other: Electronic Health Record Review; Other: Educational Activity; Other: Counseling; Other: Survey Administration; Other: Electronic Health Record Review
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • PRACTICE LEVEL:
  • Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
  • Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports
  • Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate
  • PATIENT LEVEL:
  • Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days
  • 50 to 77 years of age
  • Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment)
  • Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment)
  • Able to communicate in English or Spanish (determined at baseline eligibility assessment)
Reasons someone may not be able to joinExclusion criteria
  • PATIENT OUTREACH:
  • Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows
  • G0297 - LDCT screening
  • 71250 - CT w/o contrast
  • 71260 - CT w/ contrast
  • 71270 - CT with and w/o contrast
  • 71275 - CT angiography chest
  • 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh
  • 78816 - PET CT whole body
  • Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment)
  • Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment)
  • Dementia (diagnosis codes F03.90 or F03.91) in EHR

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphia, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 29, 2026. Always confirm current availability with the study team.

View original record ↗